You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 70000-0593


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70000-0593

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70000-0593

Understanding the NDC System

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the NDC system. The NDC is a unique three-segment number that identifies a drug product. It includes the labeler code, product code, and package code[1][4].

Identifying the Drug

The NDC 70000-0593 can be broken down as follows:

  • Labeler Code: The first segment, which could be 4 or 5 digits, identifies the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment, which could be 3 or 4 digits, identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment, which could be 1 or 2 digits, identifies the package size and type.

To proceed with the analysis, one would need to look up the specific drug associated with this NDC in the FDA's National Drug Code Directory[4].

Market Trends and Pricing

Global and US Market Context

The US prescription drug market is characterized by significantly higher prices compared to other regions. For instance, in 2022, the average price per unit in the US was 5.5 times higher than in the OECD (excluding the US) and 7.7 times higher than in the rest of the world[3].

Price Increases and Negotiations

Many prescription drugs have seen substantial price increases over recent years. For example, between 2018 and 2023, nine out of ten drugs selected for the Medicare Drug Price Negotiation Program saw list price increases ranging from 20% to 55%[2].

Medicare Drug Price Negotiation Program

The Medicare Drug Price Negotiation Program, part of the Inflation Reduction Act, aims to reduce prescription drug costs for Medicare beneficiaries. Starting in January 2026, negotiated prices for the first set of selected drugs will go into effect, resulting in significant discounts compared to list prices. For instance, the negotiated price for Januvia (an example drug) is expected to be $113.00 for a 30-day supply, down from a list price of $527.00, representing a 79% discount[5].

Price Projections for NDC 70000-0593

Current Pricing

To project future prices, one must first determine the current pricing of the drug associated with NDC 70000-0593. This involves checking the FDA's NDC Directory and other market data sources for the current list price and any recent price changes.

Impact of Negotiations and Regulatory Changes

If the drug associated with NDC 70000-0593 is selected for future negotiation cycles under the Medicare Drug Price Negotiation Program, it could see significant price reductions. For example, if it is selected for the second cycle of negotiations in 2027, the negotiated price could be substantially lower than the current list price, similar to the discounts seen in the first cycle of negotiations[5].

Market Dynamics

The overall market dynamics, including competition, demand, and regulatory changes, will also influence the price of the drug. For instance, if there are generic or biosimilar alternatives entering the market, this could drive down prices. Additionally, changes in healthcare policies or reimbursement rates can impact the drug's pricing.

Data Analysis

Historical Price Trends

Analyzing historical price trends for the drug can provide insights into potential future price movements. If the drug has seen consistent price increases in the past, it may continue this trend unless affected by external factors such as negotiations or market competition.

Comparative Analysis

Comparing the pricing of the drug with similar products in the market can also help in projecting future prices. For example, if similar drugs have seen significant price reductions due to negotiations or generic competition, it is likely that the drug associated with NDC 70000-0593 could follow a similar pattern.

Key Takeaways

  • NDC System: Understanding the NDC system is crucial for identifying and analyzing the drug.
  • Market Context: The US prescription drug market is characterized by high prices, with significant increases over recent years.
  • Negotiation Program: The Medicare Drug Price Negotiation Program can lead to substantial price reductions for selected drugs.
  • Regulatory Impact: Regulatory changes and market dynamics will influence future price projections.
  • Data Analysis: Historical price trends and comparative analysis are essential for accurate price projections.

FAQs

What is the NDC Directory?

The NDC Directory is a database maintained by the FDA that contains information about finished and unfinished drug products, including their unique National Drug Codes (NDCs)[4].

How do Medicare negotiations affect drug prices?

Medicare negotiations under the Inflation Reduction Act can result in significant discounts for selected drugs, with negotiated prices often 20-79% lower than list prices[2][5].

Why are US drug prices higher than in other countries?

US drug prices are higher due to a combination of factors, including higher prices for the same drugs and a drug mix that skews towards more expensive compounds[3].

How often is the NDC Directory updated?

The NDC Directory is updated daily to ensure it includes the most current information on listed drugs in US commercial distribution[1][4].

What types of drugs are included in the NDC Directory?

The NDC Directory includes information on all electronically listed drugs in their final marketed form, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged and relabeled drugs[1][4].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.